Shares of Merck KGaA (OTCMKTS:MKKGY – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares trading hands. The stock had previously closed at $29.22.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating on the stock.
Get Our Latest Research Report on Merck KGaA
Merck KGaA Stock Performance
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Articles
- Five stocks we like better than Merck KGaA
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Buy P&G Now, Before It Sets A New All-Time High
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.